Irinotecan- vs. Oxaliplatin-Based Doublets in KRAS G12C -Mutated Metastatic Colorectal Cancer-A Mult...
Irinotecan- vs. Oxaliplatin-Based Doublets in KRAS G12C -Mutated Metastatic Colorectal Cancer-A Multicentre Propensity-Score-Matched Retrospective Analysis
About this item
Full title
Author / Creator
Formica, Vincenzo , Morelli, Cristina , Conca, Veronica , Calegari, Maria Alessandra , Lucchetti, Jessica , Dell'Aquila, Emanuela , Schirripa, Marta , Messina, Marco , Salvatore, Lisa , Lo Prinzi, Federica , Dima, Giovanni , Trovato, Giovanni , Riondino, Silvia , Roselli, Mario , Skoulidis, Ferdinandos , Arkenau, Hendrik-Tobias and Cremolini, Chiara
Publisher
Switzerland
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland
More information
Scope and Contents
Contents
KRAS
-mutated metastatic colorectal cancer (mCRC) has recently been recognized as a distinct druggable molecular entity; however, there are limited data on its sensitivity to standard chemotherapy. In the near future, the combination of chemotherapy plus a KRAS
-inhibitor might become the standard of care; however, the optimal chemotherapy ba...
Alternative Titles
Full title
Irinotecan- vs. Oxaliplatin-Based Doublets in KRAS G12C -Mutated Metastatic Colorectal Cancer-A Multicentre Propensity-Score-Matched Retrospective Analysis
Authors, Artists and Contributors
Author / Creator
Morelli, Cristina
Conca, Veronica
Calegari, Maria Alessandra
Lucchetti, Jessica
Dell'Aquila, Emanuela
Schirripa, Marta
Messina, Marco
Salvatore, Lisa
Lo Prinzi, Federica
Dima, Giovanni
Trovato, Giovanni
Riondino, Silvia
Roselli, Mario
Skoulidis, Ferdinandos
Arkenau, Hendrik-Tobias
Cremolini, Chiara
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_37297026
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_37297026
Other Identifiers
ISSN
2072-6694
E-ISSN
2072-6694
DOI
10.3390/cancers15113064
